€10.44
1.51%
Madrid, Sep 18, 05:35 pm CEST. Closed.
ISIN
ES0157097017
Symbol
ALM
Sector
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals

Almirall Stock News

Almirall
●
●
about 2 months ago
Almirall Q2 2026 Earnings Call Transcript and Presentation available
Show summary
Earnings Call Transcript
Neutral
Almirall
●
Business Wire
●
2 months ago
Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older
BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced that the European Medicines Agency (EMA) has accepted the submission of the extension of the Marketing Authorisation Application (MAA) of Ebglyss® (lebrikizumab) for the treatment of children and adolescents aged 6 months to

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today